| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |